Drug Shortage Report for ODAN-SODIUM POLYSTYRENE SULFONATE

Last updated on 2023-10-05 History
Report ID 93479
Drug Identification Number 02473968
Brand name ODAN-SODIUM POLYSTYRENE SULFONATE
Common or Proper name Sodium Polystyrene Sulfonate Oral/Rectal Suspension
Company Name ODAN LABORATORIES LTD
Market Status MARKETED
Active Ingredient(s) SODIUM POLYSTYRENE SULFONATE
Strength(s) 250MG
Dosage form(s) SUSPENSION
Route of administration ORAL RECTAL
Packaging size 500 mL
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-01
Estimated end date 2023-10-25
Actual end date 2023-10-04
Shortage status Resolved
Updated date 2023-10-05
Company comments
Health Canada comments
Tier 3 Status No
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-11-05 English Compare
v12 2020-09-02 French Compare
v11 2020-09-02 English Compare
v10 2020-02-19 French Compare
v9 2020-02-19 English Compare
v8 2020-01-13 French Compare
v7 2020-01-13 English Compare
v6 2019-12-20 French Compare
v5 2019-12-20 English Compare
v4 2019-10-22 French Compare
v3 2019-10-22 English Compare
v2 2019-09-10 French Compare
v1 2019-09-10 English Compare

Showing 21 to 33 of 33